Structures by: Guru Row T. A.
Total: 145
C10H8N2,2(C4H7NO3)
C10H8N2,2(C4H7NO3)
Crystal Growth & Design (2014) 14, 8 4187
a=7.1751(6)Å b=10.1669(12)Å c=12.6992(12)Å
α=82.037(9)° β=81.412(7)° γ=88.251(8)°
3-acetylcoumarin
C11H8O3
Crystal Growth & Design (2006) 6, 3 708
a=7.4772(15)Å b=9.6304(19)Å c=11.9893(2)Å
α=85.751(11)° β=86.099(11)° γ=81.753(11)°
3-acetylcoumarin
C11H8O3
Crystal Growth & Design (2006) 6, 3 708
a=11.3068(7)Å b=3.9871(2)Å c=18.7586(11)Å
α=90.00° β=90.454(2)° γ=90.00°
3-acetylcoumarin
C11H8O3
Crystal Growth & Design (2004) 4, 6 1105
a=11.325(7)Å b=3.987(2)Å c=18.773(11)Å
α=90° β=90.425(10)° γ=90°
3-acetylcoumarin
C11H8O3
Crystal Growth & Design (2004) 4, 6 1105
a=7.496(4)Å b=9.653(6)Å c=12.002(7)Å
α=85.740(9)° β=86.097(9)° γ=81.728(9)°
2,6-difluorobenzoylcarvacryl thiourea
C18H18F2N2O2S
Crystal Growth & Design (2012) 12, 9 4530
a=23.4200(19)Å b=10.7880(9)Å c=13.5978(12)Å
α=90° β=95.991(3)° γ=90°
2-fluorobenzoylcarvacryl thiourea, Form IA
C18H19FN2O2S
Crystal Growth & Design (2012) 12, 9 4530
a=10.0715(4)Å b=14.8192(7)Å c=11.8886(6)Å
α=87.715(4)° β=90.239(3)° γ=89.911(3)°
2-fluoro benzoyl carvacrol thiourea, FormIB
C18H19FN2O2S
Crystal Growth & Design (2012) 12, 9 4530
a=10.0148(18)Å b=14.780(3)Å c=11.601(2)Å
α=90° β=90.796(3)° γ=90°
2-fluorobenzoylcarvacryl thiourea, Form II
C18H18FN2O2S
Crystal Growth & Design (2012) 12, 9 4530
a=23.5271(12)Å b=10.7467(6)Å c=13.5653(9)Å
α=90° β=97.631(5)° γ=90°
C18H2F10N2S2
C18H2F10N2S2
Crystal Growth & Design (2013) 13, 3 1045
a=4.9358(3)Å b=9.9438(5)Å c=16.7977(8)Å
α=90° β=90.352(5)° γ=90°
C18Br2F10N2S2
C18Br2F10N2S2
Crystal Growth & Design (2013) 13, 3 1045
a=9.9430(5)Å b=15.7223(7)Å c=6.2495(3)Å
α=90° β=101.142(2)° γ=90°
2,5-dichloro 1,4-benzoquinone
C6H2Cl2O2
Crystal Growth & Design (2011) 11, 5 1855
a=6.0187(3)Å b=5.3451(3)Å c=9.9651(4)Å
α=90° β=92.604(2)° γ=90°
2,2'-((octyl-9H-fluorene-2,7-diyl)bis(4,1 phenylene))bisbenzo[d]thiazole
C55H56N2S2
Crystal Growth & Design (2011) 11, 5 1615
a=8.2872(4)Å b=14.9135(9)Å c=17.9141(10)Å
α=88.609(5)° β=88.098(4)° γ=86.185(5)°
2,2'-((9,9-butyl-9H-fluorene-2,7-diyl)bis(4,1 phenylene))bisbenzo[d]thiazole
C94H60N4S4,2(C47H40N2S2)
Crystal Growth & Design (2011) 11, 5 1615
a=9.5194(7)Å b=13.0361(9)Å c=31.562(2)Å
α=80.674(6)° β=85.783(5)° γ=68.813(6)°
2,2'-((9,9-butyl-9H-fluorene-2,7-diyl)bis(4,1 phenylene))bisbenzo[d]thiazole
C47H40N2S2
Crystal Growth & Design (2011) 11, 5 1615
a=17.9801(7)Å b=14.3419(5)Å c=14.8689(7)Å
α=90° β=109.381(5)° γ=90°
2,2'-((octyl-9H-fluorene-2,7-diyl)bis(4,1 phenylene))bisbenzo[d]thiazole
C55H56N2S2
Crystal Growth & Design (2011) 11, 5 1615
a=16.2922(8)Å b=17.2859(8)Å c=17.3329(6)Å
α=88.728(3)° β=66.285(4)° γ=80.992(4)°
2-chloro-4-fluoro benzoic acid
C7H4ClFO2
Crystal Growth & Design (2011) 11, 4 1338
a=3.7321(1)Å b=7.7308(2)Å c=12.0995(4)Å
α=77.092(2)° β=85.070(2)° γ=76.459(2)°
4-fluoro benzamide
C7H6FNO
Crystal Growth & Design (2011) 11, 4 1338
a=8.8715(3)Å b=7.6301(3)Å c=9.6077(3)Å
α=90° β=92.576(2)° γ=90°
Na1.74O3.36,2(Cd2Na),9.174(O),3.162(O),2.826(O),2.838(O),2.64(O),6(Na)
Na1.74O3.36,2(Cd2Na),9.174(O),3.162(O),2.826(O),2.838(O),2.64(O),6(Na)
Crystal Growth & Design (2011) 11, 7 3213
a=15.6033(2)Å b=15.6033(2)Å c=8.8392(1)Å
α=90° β=90° γ=120°
CdH8O12S2,2(Na)
CdH8O12S2,2(Na)
Crystal Growth & Design (2011) 11, 7 3213
a=5.5314(2)Å b=8.4624(3)Å c=11.3048(4)Å
α=90° β=99.411(4)° γ=90°
CdH4O10S2,2(Na)
CdH4O10S2,2(Na)
Crystal Growth & Design (2011) 11, 7 3213
a=5.9085(3)Å b=13.0165(5)Å c=5.5636(2)Å
α=90° β=106.215(5)° γ=90°
ANHYDROUS CIPROFLOXACIN
C17H18FN3O3
Crystal Growth & Design (2010) 10, 4 1866
a=8.0622(15)Å b=9.730(2)Å c=10.3214(19)Å
α=99.927(17)° β=104.541(17)° γ=98.073(17)°
Medazolam
C18H13ClFN3
Crystal Growth & Design (2010) 10, 4 1866
a=7.5588(3)Å b=13.6840(5)Å c=15.1242(8)Å
α=90° β=92.497(5)° γ=90°
Anhydrous Ofloxacin
C18H20FN3O4
Crystal Growth & Design (2010) 10, 4 1866
a=30.322(4)Å b=6.8607(8)Å c=16.9199(16)Å
α=90° β=105.271(11)° γ=90°
C8H4F4O
C8H4F4O
Crystal Growth & Design (2007) 7, 5 868
a=10.456(3)Å b=9.592(3)Å c=7.806(2)Å
α=90° β=102.790(5)° γ=90°
C8H4ClF3O
C8H4ClF3O
Crystal Growth & Design (2007) 7, 5 868
a=7.478(3)Å b=9.884(4)Å c=11.222(5)Å
α=90° β=90° γ=90°
C8H4BrF3O
C8H4BrF3O
Crystal Growth & Design (2007) 7, 5 868
a=11.862(10)Å b=10.237(9)Å c=7.298(6)Å
α=90° β=101.110(15)° γ=90°
C10H3F5O3
C10H3F5O3
Crystal Growth & Design (2007) 7, 5 844
a=7.485(5)Å b=17.964(11)Å c=7.624(5)Å
α=90.00° β=97.103(11)° γ=90.00°
C8H4BrF3O
C8H4BrF3O
Crystal Growth & Design (2007) 7, 5 868
a=4.5037(17)Å b=14.915(6)Å c=12.927(5)Å
α=90° β=90.456(6)° γ=90°
C10H3F5O3
C10H3F5O3
Crystal Growth & Design (2007) 7, 5 844
a=7.3166(11)Å b=17.769(3)Å c=7.4574(12)Å
α=90.00° β=98.305(2)° γ=90.00°
C8H4F3NO3
C8H4F3NO3
Crystal Growth & Design (2007) 7, 5 868
a=11.838(3)Å b=6.7278(17)Å c=10.692(3)Å
α=90° β=90° γ=90°
Gallic acid monohydrate acetamide
C7H6O5,C2H5NO
Crystal Growth & Design (2012) 12, 6 2744
a=9.6400(2)Å b=10.4477(2)Å c=10.4032(3)Å
α=90° β=107.908(3)° γ=90°
Gallic acid monohydrate acetamide
C7H6O5,3(C2H5NO)
Crystal Growth & Design (2012) 12, 6 2744
a=7.1860(3)Å b=7.9309(4)Å c=14.6006(8)Å
α=82.635(4)° β=82.395(4)° γ=87.086(4)°
Gallic acid monohydrate acetamide
C7H6O5,C2H5NO
Crystal Growth & Design (2012) 12, 6 2744
a=4.2630(2)Å b=22.5002(10)Å c=10.0489(3)Å
α=90° β=92.868(3)° γ=90°
Gallic acid monohydrate acetamide
C7H6O5,C2H5NO
Crystal Growth & Design (2012) 12, 6 2744
a=28.342(6)Å b=4.9027(4)Å c=20.113(4)Å
α=90° β=134.53(4)° γ=90°
2-acetoxybenzoic acid
C9H8O4
Crystal Growth & Design (2012) 12, 9 4357
a=11.2680(8)Å b=6.5498(4)Å c=11.2646(7)Å
α=90.00° β=95.933(4)° γ=90.00°
Ferulic acid
C10H10O4
Crystal Growth & Design (2012) 12, 12 6083
a=4.58870(10)Å b=16.7619(2)Å c=11.7853(2)Å
α=90° β=91.8520(10)° γ=90°
Lithium D-isoascorbate
C6H9LiO7
Crystal Growth & Design (2013) 13, 1 97
a=7.7839(3)Å b=8.7456(3)Å c=11.0365(4)Å
α=90.00° β=90.00° γ=90.00°
C20H12F2NO3
C20H12F2NO3
Crystal Growth & Design (2006) 6, 6 1267
a=9.207(6)Å b=9.775(6)Å c=10.656(6)Å
α=106.630(10)° β=95.219(11)° γ=113.286(10)°
C20H11F2NO3,0.5(C6H12)
C20H11F2NO3,0.5(C6H12)
Crystal Growth & Design (2006) 6, 6 1267
a=7.9036(13)Å b=10.2216(17)Å c=12.435(2)Å
α=95.269(3)° β=95.215(3)° γ=96.239(3)°
C12H12N2O8
C12H12N2O8
Crystal Growth & Design (2015) 15, 2 858
a=6.2822(2)Å b=13.4037(4)Å c=15.5274(6)Å
α=90.00° β=93.563(3)° γ=90.00°
Benzoylcarvacryl thiourea
C18H20N2O2S
Crystal Growth & Design (2012) 12, 9 4530
a=23.4872(11)Å b=10.7385(5)Å c=13.6376(8)Å
α=90° β=98.421(5)° γ=90°
Gallic acid monohydrate acetamide
C7H6O5,C2H5NO
Crystal Growth & Design (2012) 12, 6 2744
a=5.1914(2)Å b=18.9993(6)Å c=10.0732(3)Å
α=90° β=100.331(3)° γ=90°
I6N8Pb2
I6N8Pb2
The journal of physical chemistry letters (2016) 7, 13 2412-2419
a=8.8117(8)Å b=8.8117(8)Å c=12.674(2)Å
α=90° β=90° γ=90°
CH6I3NPb
CH6I3NPb
The journal of physical chemistry letters (2016) 7, 13 2412-2419
a=8.8767(9)Å b=12.6400(14)Å c=8.5879(10)Å
α=90° β=90° γ=90°